In recent weeks, both Amstelland Hospital and Zilveren Kruis Achmea have considered the success of the DDD partnership with i2i. Amstelland Hospital is the first hospital in the Netherlands where all specialisms demonstrably deliver effective care. I2i and the Amstelland hospital will also continue to work together in the future to ensure efficiency within the hospital.
Curious about the entire article? Then look at Amstelland Hospital
13 March 2019
Gelre Ziekenhuizen is a large top clinical hospital with locations in Apeldoorn and Zutphen. They have recently made long-term agreements with Zilveren Kruis Achmea about smarter organization of care and reducing administrative burdens. The aim of this contract is to strive for and guarantee high-quality, accessible and affordable care in the region of Gelre Hospitals. I2i is proud that we can fulfill the facilitating role with this DDD partnership. By devoting itself to this, Gelre is given room to invest in the transition from care in the hospital to the home situation. Examples of this are forms of e-health that make it less necessary for patients to come to the hospital, but also to home administration of oncolytics and immunotherapy through a collaboration with Verian and Sensire. Edwin Maalderink, member of the Board of Directors of Gelre Hospitals, is enthusiastic and wants to rise to the challenge of keeping good quality, affordable and accessible healthcare in the region.
1 February 2019
There is growing interest abroad in the practical applications of Value Based Health Care in the Netherlands. At the invitation of ICHOM (International Consortium for Health Based Outcomes), i2i spoke at congresses in Helsinki, Barcelona and Brussels about value-oriented care in the Netherlands and how we facilitate hospitals in improving this with fact-based insights into costs and quality. Topics discussed included the importance of an ecosystem for sensible care and the Menzis Value-Oriented Procurement initiative
7 November 2018
A euro can only be spent once. Also in healthcare. Therefore it is important to consider that the care provided in hospitals is useful and effective. Of course without losing sight of the patient. In order to find out where things are going well and where things can be improved, Treant is 'tested' by the independent agency i2i that deals with useful and efficient declarations. Result: the first quality marks can be received.
Of the 20 specialisms, 12 have now proven to be effective and sensible when it comes to healthcare funds. The other 8 are still in the process and hope to get the certificate next year. This concerns the specialisms cardiology, lung medicine, internal medicine, MDL, geriatrics, dermatology, pediatrics, gynecology / obstetrics, dental surgery, anesthesiology, neurology and rheumatology. Today they proudly received the quality mark from chairman of the medical staff (MSCT) Peter Kleingeld, CFO Jean-Pierre van Beers, director Bob Smits and relationship managers Anne Jansen and Lise Gunneweg from i2i.
The i2i agency is a party that checks for Treant whether the care is provided efficiently and effectively. They do this through the system of Effective Direct Declarations – DDD . For example, Treant's claims are continuously compared with those from other hospitals with similar patients. If there are declarations that deviate from the national average, then Treant's doctors will examine why. If there is no clear explanation, an improvement process can be set up.
Treant is proud of the fact that so many specialisms have since proven to provide sensible care. The DDD partnership between i2i and Treant is supported by Zilveren Kruis. It gives the health insurer the confidence that participating hospitals take responsibility for providing effective care.
26 October 2018
On October 19, 2018, i2i was invited to the GENiE conference in Copenhagen organized by Harvard Business School to give its vision in a panel discussion about Digital Health Innovations.
On behalf of i2i, Michel Taal spoke about "overhyped" AI in healthcare (such as deep learning, quantified self / wearables) and underexposed themes such as explainable AI and AI as a tool (vs a solution)